268 related articles for article (PubMed ID: 7717793)
1. Prolonged use of methotrexate for sarcoidosis.
Lower EE; Baughman RP
Arch Intern Med; 1995 Apr; 155(8):846-51. PubMed ID: 7717793
[TBL] [Abstract][Full Text] [Related]
2. [Value of methotrexate in a case of florid cutaneous sarcoidosis].
Morin G; De Wazières B; Humbert P; Dupond JL
Ann Dermatol Venereol; 1993; 120(2):143-6. PubMed ID: 8363307
[TBL] [Abstract][Full Text] [Related]
3. Use of methotrexate in sarcoid-associated optic neuropathy.
Maust HA; Foroozan R; Sergott RC; Niazi S; Weibel S; Savino PJ
Ophthalmology; 2003 Mar; 110(3):559-63. PubMed ID: 12623821
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of neurological sarcoidosis.
Lower EE; Broderick JP; Brott TG; Baughman RP
Arch Intern Med; 1997 Sep; 157(16):1864-8. PubMed ID: 9290546
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate treatment for sarcoid-associated panuveitis.
Dev S; McCallum RM; Jaffe GJ
Ophthalmology; 1999 Jan; 106(1):111-8. PubMed ID: 9917790
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.
Kremer JM; Habros JS; Kolba KS; Kaine JL; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisemandle W; Mekki QA;
Arthritis Rheum; 2003 Oct; 48(10):2763-8. PubMed ID: 14558080
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA
Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503
[TBL] [Abstract][Full Text] [Related]
9. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
Zoller L; Ramon M; Bergman R
Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T
Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
[TBL] [Abstract][Full Text] [Related]
11. Muscle involvement in sarcoidosis: a retrospective and followup studies.
Fayad F; Lioté F; Berenbaum F; Orcel P; Bardin T
J Rheumatol; 2006 Jan; 33(1):98-103. PubMed ID: 16395757
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate for lung transplant recipients with steroid-resistant acute rejection.
Cahill BC; O'Rourke MK; Strasburg KA; Savik K; Jessurun J; Bolman RM; Hertz MI
J Heart Lung Transplant; 1996 Nov; 15(11):1130-7. PubMed ID: 8956122
[TBL] [Abstract][Full Text] [Related]
13. An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment.
Pastores GM; Barnett NL; Kolodny EH
Clin Ther; 2005 Aug; 27(8):1215-27. PubMed ID: 16199246
[TBL] [Abstract][Full Text] [Related]
14. [The effect of therapeutic intervention with corticosteroids on outcome and prognosis of sarcoidosis].
Miao JZ; Du DJ; Zeng P
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jan; 26(1):14-7. PubMed ID: 12775262
[TBL] [Abstract][Full Text] [Related]
15. Presentations and outcomes of neurosarcoidosis: a study of 54 cases.
Pawate S; Moses H; Sriram S
QJM; 2009 Jul; 102(7):449-60. PubMed ID: 19383611
[TBL] [Abstract][Full Text] [Related]
16. Sarcoidosis.
Wu JJ; Schiff KR
Am Fam Physician; 2004 Jul; 70(2):312-22. PubMed ID: 15291090
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.
Ravelli A; Ballardini G; Viola S; Villa I; Ruperto N; Martini A
J Rheumatol; 1998 Mar; 25(3):572-5. PubMed ID: 9517783
[TBL] [Abstract][Full Text] [Related]
18. Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients.
Scott TF; Yandora K; Valeri A; Chieffe C; Schramke C
Arch Neurol; 2007 May; 64(5):691-6. PubMed ID: 17502468
[TBL] [Abstract][Full Text] [Related]
19. Recalcitrant cutaneous sarcoidosis: an evidence-based sequential approach.
Mosam A; Morar N
J Dermatolog Treat; 2004 Dec; 15(6):353-9. PubMed ID: 15764046
[TBL] [Abstract][Full Text] [Related]
20. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
Kremer JM; Weinblatt ME; Bankhurst AD; Bulpitt KJ; Fleischmann RM; Jackson CG; Atkins KM; Feng A; Burge DJ
Arthritis Rheum; 2003 Jun; 48(6):1493-9. PubMed ID: 12794815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]